Dinh, Bui Bao Khanh
Aziz, Waseem Hamed
Terruzzi, Alessandro
Krieger, Derk Wolfgang
Article History
Received: 21 September 2021
Accepted: 11 November 2021
First Online: 14 December 2021
Declarations
:
: This study complied with the recommendations of the 18th World Health Congress (Helsinki, 1964) and all the applicable amendments, as well as the laws and regulations and any applicable guidelines of the United Arab Emirates (UAE) where the study was conducted. The study’s protocol was reviewed and approved by the Dubai Healthcare City Authority – Regulatory Review Ethics Committee (DHCR Rec 2021 10 MCH Migraine). Informed consent was waived by the Dubai Healthcare City Authority – Regulatory Review Ethics Committee (DHCR Rec 2021 10 MCH Migraine) as it was not required due to the retrospective nature of the study and considering that there was no associated risk.
: Not applicable.
: Dr. Alessandro Terruzzi and Dr. Derk Wolfgang Krieger are on Novartis advisory board. Dr. Waseem Hamed Aziz and Bui Bao Khanh Dinh have no conflict of interest.